S Maher1,2, Z Mikic3, C McDonald1,4, G T Flaherty1,5, B Hallahan1,4. 1. School of Medicine, Clinical Science Institute, National University of Ireland Galway, University Hospital Galway, Galway Roscommon Mental Health Services, Galway, Ireland. 2. University Hospital Galway, Galway, Ireland. 3. Cork University Hospital, Cork, Ireland. 4. University Hospital Galway, Galway Roscommon Mental Health Services, National University of Ireland Galway, Galway, Ireland. 5. School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
Abstract
OBJECTIVES: To identify factors influencing successful international travel among patients with psychotic illness. METHODS: Eight individuals participated in a semi-structured interview of 15-20-minute duration with a clinician in relation to their recent experience of international travel. Clinical files were reviewed and a case series was compiled. RESULTS: Four individuals engaged in international travel without any adverse effects. Four other individuals experienced significant psychotic and/or affective symptoms while travelling. Treatment non-adherence, a lack of awareness of how to obtain support and limited or no pre-travel planning were noted in these individuals. CONCLUSIONS: Pre-travel counselling, treatment adherence, provision of information packages relating to their mental illness and having contact details of their treating mental health team increase the likelihood of successful international travel in patients with psychotic illness. Travelling with a companion may reduce fear of relapse.
OBJECTIVES: To identify factors influencing successful international travel among patients with psychotic illness. METHODS: Eight individuals participated in a semi-structured interview of 15-20-minute duration with a clinician in relation to their recent experience of international travel. Clinical files were reviewed and a case series was compiled. RESULTS: Four individuals engaged in international travel without any adverse effects. Four other individuals experienced significant psychotic and/or affective symptoms while travelling. Treatment non-adherence, a lack of awareness of how to obtain support and limited or no pre-travel planning were noted in these individuals. CONCLUSIONS: Pre-travel counselling, treatment adherence, provision of information packages relating to their mental illness and having contact details of their treating mental health team increase the likelihood of successful international travel in patients with psychotic illness. Travelling with a companion may reduce fear of relapse.